OXFORD, England, July 15 /PRNewswire/ --
- Senior Executives at Pfizer, Johnson & Johnson, GlaxoSmithKline, and Other Big Pharma use New Media to Bring Fresh Exchange
PharmaTelevision, the authoritative channel for the pharmaceutical, biotechnology and related industries, announced today the launch of its new service, PharmaTelevision Premium Content. PTV Premium Content will include PTV News - a daily news and analysis service to be launched in August. Subscription to the service will be free until 30 September, 2009. Dr Fintan Walton, CEO of PharmaVentures - the company behind PharmaTelevision - said, "Television captures and delivers something unique, recognising that business is ultimately about the people in it - whether it's a part of deal making, or discovery and development, or about a company's ability to finance itself. It's not a surprise to us that PharmaTelevision has become 'must view' TV for many senior executives and managers".
Dr Walton continues, "Launch of this new service means we can deliver to our subscribers great television programming and integrated news and analysis information services." PharmaTelevision addresses the current issues and future predictions of the industry, including those of the top companies, through news, analysis, interviews, panels and discussions. Interviewees come from companies such as Johnson & Johnson, Merck & Co., sanofi-aventis, Genzyme, MerckSerono, NICE UK, and Roche. As well as PTV News, current programmes include PharmaVentures Business Review; The Regional Report; The Financial Report; and PharmaDeals(R) Commentaries, and bring the major industry players straight to desktops - on demand from the viewer.
Dr Walton says, "This year, development to PharmaTelevision has been
rapid as we meet the demand from our discerning audience. Our subscribers can
look forward to significant upgrades that help them uncover fu
'/>"/>
| SOURCE PharmaVentures Copyright©2009 PR Newswire. All rights reserved |